Cargando…

Has the rheumatoid arthritis (RA) core outcome set influenced the selection of study outcome measures?

Detalles Bibliográficos
Autores principales:	Kirkham, Jamie, Boers, Maarten, Tugwell, Peter, Clarke, Mike, Williamson, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981028/ http://dx.doi.org/10.1186/1745-6215-14-S1-O66

Ejemplares similares

Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
por: Kirkham, Jamie J, et al.
Publicado: (2013)

Citation analysis: a new approach to assess the uptake of core outcome sets
por: Barnes, Karen, et al.
Publicado: (2015)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

A survey of core outcome set developers
por: Gargon, Elizabeth, et al.
Publicado: (2015)

A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis
por: Kirkham, Jamie J, et al.
Publicado: (2017)

The COMET (Core Outcome Measures in Effectiveness Trials) Initiative
por: Williamson, Paula R, et al.
Publicado: (2011)

How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline
por: Prinsen, Cecilia A. C., et al.
Publicado: (2016)

Design considerations in the development of a core outcome set
por: Harman, Nicola, et al.
Publicado: (2013)

Selective reporting in clinical trials - an examination of discrepancy rates in pre-specified and reported outcomes in articles submitted to the BMJ
por: Weston, Jennifer, et al.
Publicado: (2015)

Core outcome sets in medical research
por: Kirkham, Jamie J, et al.
Publicado: (2022)

Assessing the impact of a research funder’s recommendation to consider core outcome sets
por: Hughes, Karen L., et al.
Publicado: (2019)

Core Outcome Set–STAndards for Reporting: The COS-STAR Statement
por: Kirkham, Jamie J., et al.
Publicado: (2016)

Citation analysis did not provide a reliable assessment of core outcome set uptake
por: Barnes, Karen L., et al.
Publicado: (2017)

Skeletal involvement in the pathogenesis and outcomes of rheumatoid arthritis and osteoarthritis
por: Pelletier, Jean-Pierre
Publicado: (2012)

Core Outcome Set-STAndards for Development: The COS-STAD recommendations
por: Kirkham, Jamie J., et al.
Publicado: (2017)

Core outcome sets and trial registries
por: Clarke, Mike, et al.
Publicado: (2015)

Can a core outcome set improve the quality of systematic reviews? – a survey of the Co-ordinating Editors of Cochrane review groups
por: Kirkham, Jamie J, et al.
Publicado: (2013)

Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement
por: Kirkham, Jamie J., et al.
Publicado: (2019)

Developing core outcome sets for clinical trials: issues to consider
por: Williamson, Paula R, et al.
Publicado: (2012)

Core outcome sets and systematic reviews
por: Clarke, Mike, et al.
Publicado: (2016)

Guidance to detect, evaluate and prevent the problem of selective reporting in trial publications
por: Dwan, Kerry, et al.
Publicado: (2013)

Collating the knowledge base for the COMET (core outcome measures in effectiveness trials) initiative - a systematic review
por: Gargon, Elizabeth, et al.
Publicado: (2013)

19. A case of giant cell arteritis (GCA) co-existent with systemic lupus erythematosus (SLE)/rheumatoid arthritis (RA) overlap syndrome
por: Steward, Matthew, et al.
Publicado: (2019)

COS-STAR: a reporting guideline for studies developing core outcome sets (protocol)
por: Kirkham, Jamie J., et al.
Publicado: (2015)

What is the effect of patient-reported outcome (PRO) item order on prioritisation of PROs in the development of a core outcome set?
por: Chalmers, Katy, et al.
Publicado: (2015)

Development of the Salford Rheumatoid Arthritis Foot Evaluation Instrument (SAFE)
por: Walmsley, Steven, et al.
Publicado: (2013)

Markers in rheumatoid arthritis
por: Breedveld, FC
Publicado: (2004)

Using behavioural science to enhance use of core outcome sets in trials: protocol
por: Matvienko-Sikar, Karen, et al.
Publicado: (2023)

Using existing trial data to inform the development of core outcome sets and improve efficiencies in research
por: Thomas, Kim S, et al.
Publicado: (2015)

Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis
por: Vastert, SJ, et al.
Publicado: (2011)

A minimum core outcome set for clinical trials on non-minimal-invasive off- or on-pump cardiothoracic surgery
por: Benstöm, Carina, et al.
Publicado: (2015)

IFN-β for the treatment of rheumatoid arthritis?
por: Tak, P, et al.
Publicado: (2003)

OA17 Rheumatoid meningitis - a rare complication of rheumatoid arthritis
por: Ibrahim, Asma, et al.
Publicado: (2023)

Evidence for synovial fibroblasts spreading rheumatoid arthritis
por: Müller-Ladner, Ulf, et al.
Publicado: (2012)

Signal transduction inhibitors for the treatment of rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2012)

IL-17, synoviolin and rheumatoid arthritis chronicity
por: Miossec, Pierre
Publicado: (2012)

Angiogenesis in rheumatoid arthritis: the role of fut 1
por: Koch, Alisa Erika
Publicado: (2012)

Adverse effects of rheumatoid arthritis on bone remodeling
por: Goldring, SR, et al.
Publicado: (2004)

The bacterial effector protein YopM reduces rheumatoid arthritis (RA) outcome by inhibiting inflammation and bone destruction
por: Bertrand, J, et al.
Publicado: (2012)

Assessing the relevance and uptake of core outcome sets (an agreed minimum collection of outcomes to measure in research studies) in Cochrane systematic reviews: a review
por: Williamson, Paula R, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rabnuvofa99b5jkgu27hegq77h